Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Highly Accessed Review

Developments in the scientific understanding of lupus

Stacy P Ardoin1* and David S Pisetsky2

Author Affiliations

1 Departments of Pediatrics and Medicine, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA

2 Medical Research Service, Durham VA Hospital, Durham, North Carolina, 508 Fulton Street, Durham, NC 27705, USA

For all author emails, please log on.

Arthritis Research & Therapy 2008, 10:218  doi:10.1186/ar2488

Published: 10 October 2008

Abstract

Systemic lupus erythematosus is a systemic autoimmune disease characterized by the production of antinuclear antibodies (ANAs). Recent research into human and murine lupus suggests that disease susceptibility results from genetic polymorphisms regulating immune responses as well as impairing the clearance of apoptotic cells. Because the products of dead cells, including nucleic acids, have immunologic activity, this situation can promote antigen-driven ANA responses. Furthermore, immune complexes of ANAs can drive the production of proinflammatory cytokines, inducing the 'interferon signature', and intensifying disease. Together, these findings point to new genetic and immunologic markers of disease as well as targets for new therapies.